Trial intelligence / Profile preview

INFUSE-NSLR: Hylenex-enabled Subcutaneous Hydration

NCT00656370Phase 4Completed

Sponsor
Halozyme Therapeutics, Inc.
Start
Dec 2007
Primary completion
Jan 2008
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 4 trial of hyaluronidase in dehydration, sponsored by Halozyme Therapeutics, Inc.. Started Dec 2007; status: completed.

02

Drugs

hyaluronidase
03

Conditions

dehydration

Beyond the preview

Go deeper on NCT00656370.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00656370.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call